Surgery CME

Credits: 1.00 CME
Medical Learning Institute, Inc.
The Path Forward for Immunotherapy in Resectable Melanoma: Principles and Perspectives on Using Immune-Based Adjuvant and Neoadjuvant Therapy
Jennifer Wargo, MD, MMSc
April 12, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
How to Manage JAK Inhibition in Patients Undergoing HCT: Applying the Latest Clinical Evidence to Improve Patient Outcomes in Myelofibrosis
Ruben A. Mesa, MD, FACP
February 26, 2021
Credits: 0.50 CME
Penn State College of Medicine
Optimizing Maintenance Immunosuppressive Therapy in Kidney Transplantation: Examining Current and Future Strategies to Preserve Graft Function and Maximize Long-Term Outcomes
Titte R. Srinivas, MD, FAST
February 25, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics
Corey Cutler, MD, MPH, FRCP(C) / Miguel-Angel Perales, MD
February 23, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
The Multiple Myeloma Workshop: Exploring the Convergence of Novel Therapeutic Platforms, Cell Therapy, and ASCT
Robert Z. Orlowski, MD, PhD
February 17, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
Charting Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCT
February 16, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Rethinking Glioblastoma Care in an Evolving Therapeutic Landscape: Expert Perspectives on Modern Modalities, Novel Agents, and Combinations
Steven Brem, MD
December 29, 2020
Credits: 1.00 CME
PeerView Institute
Preparing for the Next Leap Forward in Multimodal Management of Esophageal/GEJ Cancer: An Interdisciplinary Tumor Board on Adjuvant Immunotherapy
Ronan J. Kelly, MD, MBA
November 11, 2020
Credits: 1.00 CME
PeerView Institute
Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest Data and Practical Guidance for Thoracic Surgeons and the Multidisciplinary Team on the Emerging Role of EGFR-Targeted Therapy in Resectable Lung Cancer
David R. Jones, MD
November 11, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Taking the Leap With Immunotherapy in Resectable Melanoma: Immune Checkpoint Inhibitors as Adjuvant and Neoadjuvant Therapy and Other Intersections With Surgical Management
Jennifer Wargo, MD, MMSc
September 23, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Making the Most of the New Era of Immuno-Oncology in TNBC: Essential Guidance for Surgeons on How to Maximize the Potential of Immunotherapies and Combinations in Advanced and Early-Stage Breast Cancer
George Plitas, MD
September 21, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Antibody Therapy in Acute Leukemia: Understanding Clinical Considerations for Use in Conjunction With HSCT
Professor David I. Marks
September 18, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 25, 2020
The Medical College of Wisconsin
State-of-the-Art Solutions for Myelofibrosis: The Intersection of JAK Inhibitors, Allogeneic Transplant, and Other Strategies for Patient Care
Prithviraj Bose, MD
March 23, 2020
The Medical College of Wisconsin
Taking the Leap With CAR T: Opportunities for Improving Care and Optimizing Cell Therapy in Hematologic Cancers
Michael R. Bishop, MD
March 12, 2020
Penn State College of Medicine
Expanding Options for Prophylaxis and Treatment of Acute and Chronic GVHD: Mapping the Path to Better Patient Outcomes in Post-Transplant Care
Miguel-Angel Perales, MD
December 31, 2019